Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
South Plains Oncology Consortium
South Plains Oncology Consortium
Children's Oncology Group
Children's Oncology Group
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC